» Articles » PMID: 21261927

Overcoming the Restriction Barrier to Plasmid Transformation and Targeted Mutagenesis in Bifidobacterium Breve UCC2003

Overview
Date 2011 Jan 26
PMID 21261927
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

In silico analysis of the Bifidobacterium breve UCC2003 genome predicted two distinct loci, which encode three different restriction/modification systems, each comprising a modification methylase and a restriction endonuclease. Based on sequence homology and observed protection against restriction we conclude that the first restriction endonuclease, designated BbrI, is an isoschizomer of BbeI, the second, BbrII, is a neoschizomer of SalI, while the third, BbrIII, is an isoschizomer of PstI. Expression of each of the B. breve UCC2003 methylase-encoding genes in B. breve JCM 7017 established that BbrII and BbrIII are active and restrict incoming DNA. By exploiting knowledge on restriction/modification in B. breve UCC2003 we successfully increased the transformation efficiency to a level that allows the reliable generation of mutants by homologous recombination using a non-replicative plasmid.

Citing Articles

An improved temperature-sensitive shuttle vector system for scarless gene deletion in human-gut-associated species.

Kozakai T, Nakajima A, Miyazawa K, Sasaki Y, Odamaki T, Katoh T iScience. 2024; 27(11):111080.

PMID: 39502284 PMC: 11536034. DOI: 10.1016/j.isci.2024.111080.


GH136-encoding gene (perB) is involved in gut colonization and persistence by Bifidobacterium bifidum PRL2010.

Rizzo S, Vergna L, Alessandri G, Lee C, Fontana F, Lugli G Microb Biotechnol. 2024; 17(2):e14406.

PMID: 38271233 PMC: 10884991. DOI: 10.1111/1751-7915.14406.


Establishing genetic manipulation for novel strains of human gut bacteria.

Sheridan P, Odat M, Scott K Microbiome Res Rep. 2023; 2(1):1.

PMID: 38059211 PMC: 10696588. DOI: 10.20517/mrr.2022.13.


Biotechnological Applications of Probiotics: A Multifarious Weapon to Disease and Metabolic Abnormality.

Singh R, Shadan A, Ma Y Probiotics Antimicrob Proteins. 2022; 14(6):1184-1210.

PMID: 36121610 PMC: 9483357. DOI: 10.1007/s12602-022-09992-8.


Barriers to genetic manipulation of Enterococci: Current Approaches and Future Directions.

Krause A, Stinear T, Monk I FEMS Microbiol Rev. 2022; 46(6).

PMID: 35883217 PMC: 9779914. DOI: 10.1093/femsre/fuac036.


References
1.
Kumar S, Cheng X, Klimasauskas S, Mi S, Posfai J, Roberts R . The DNA (cytosine-5) methyltransferases. Nucleic Acids Res. 1994; 22(1):1-10. PMC: 307737. DOI: 10.1093/nar/22.1.1. View

2.
Oishi K, Sato T, Yokoi W, Yoshida Y, Ito M, Sawada H . Effect of probiotics, Bifidobacterium breve and Lactobacillus casei, on bisphenol A exposure in rats. Biosci Biotechnol Biochem. 2008; 72(6):1409-15. DOI: 10.1271/bbb.70672. View

3.
Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vos W . Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol. 2005; 16(2):204-11. DOI: 10.1016/j.copbio.2005.02.003. View

4.
Lee J, Karamychev V, Kozyavkin S, Mills D, Pavlov A, Pavlova N . Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genomics. 2008; 9:247. PMC: 2430713. DOI: 10.1186/1471-2164-9-247. View

5.
Alvarez-Martin P, OConnell-Motherway M, Van Sinderen D, Mayo B . Functional analysis of the pBC1 replicon from Bifidobacterium catenulatum L48. Appl Microbiol Biotechnol. 2007; 76(6):1395-402. DOI: 10.1007/s00253-007-1115-5. View